SCHEMBL31662318

SCHEMBL31662318

CC(C)Oc1nc(-c2cc(O)cc3ccc(F)c(Cl)c23)c(F)c2nc(OC[C@@]34CCCN3C[C@H](F)C4)nc(NCCO)c12

nearest known ligand 0.57

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KRAS P01116 19/20 0.57
MAPK3 P27361 2/20 0.50
MAPK1 P28482 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31662322 0.93 KRAS (0.59) KRASMAPK3MAPK1
SCHEMBL31662313 0.92 KRAS (0.61) KRASMAPK3MAPK1
SCHEMBL31662037 0.89 KRAS (0.51) KRASMAPK3MAPK1
SCHEMBL31662040 0.87 KRAS (0.61) KRASMAPK3MAPK1
SCHEMBL31662282 0.87 KRAS (0.62) KRASMAPK3MAPK1
SCHEMBL31662420 0.86 KRAS (0.51) KRASMAPK3MAPK1
SCHEMBL31662203 0.86 KRAS (0.60) KRASMAPK3MAPK1
SCHEMBL31662076 0.85 KRAS (0.63) KRASMAPK3MAPK1
SCHEMBL31662351 0.84 KRAS (0.61) KRASMAPK3MAPK1
SCHEMBL31662095 0.83 KRAS (0.60) KRASMAPK3MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025151594-A1 FUSED AZINES AS RAS INHIBITORS AND METHODS OF USE THEREOF KESTREL THERAPEUTICS INC. (US) 2025-07-17 WO disclosed